Correlation Between ABVC Biopharma and Rezolute
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Rezolute, you can compare the effects of market volatilities on ABVC Biopharma and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Rezolute.
Diversification Opportunities for ABVC Biopharma and Rezolute
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ABVC and Rezolute is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Rezolute go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Rezolute
Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the Rezolute. In addition to that, ABVC Biopharma is 1.84 times more volatile than Rezolute. It trades about -0.04 of its total potential returns per unit of risk. Rezolute is currently generating about -0.01 per unit of volatility. If you would invest 469.00 in Rezolute on September 24, 2024 and sell it today you would lose (30.00) from holding Rezolute or give up 6.4% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ABVC Biopharma vs. Rezolute
Performance |
Timeline |
ABVC Biopharma |
Rezolute |
ABVC Biopharma and Rezolute Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ABVC Biopharma and Rezolute
The main advantage of trading using opposite ABVC Biopharma and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
Rezolute vs. Fate Therapeutics | Rezolute vs. Sana Biotechnology | Rezolute vs. Caribou Biosciences | Rezolute vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data |